India grants first compulsory licence

No items found.
​
March 14, 2012
#
Life
Table of contents
  • Toc Heading
  • Toc Heading

The first compulsory licence has been granted by the Controller of Patents Mumbai.

The application concerns the anti-cancer drug Sorafenib, a patented drug owned by Bayer Corporation. The applicant for a compulsory licence is Natco Pharma Limited, an Indian generic pharmaceuticals company.

Darren Smyth's post on the IPKat explores the implications of this landmark decision.

Related articles

See all articles

Poland's law on cheap drugs declared contrary to EU law
03 April 2012
A Polish law which allowed the sale of unapproved drugs which were cheaper than those approved has been declared contrary to EU law.The decision by the Court of Justice of the European Union is...
​
Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc
29 March 2012
In today's IPKat, Darren Smyth analyses the decision in Regeneron Pharmaceuticals Inc, Bayer Pharma AG v Genentech Inc, a case which started as an action for a declaration of invalidity of...
​
AstraZeneca patent revoked for obviousness
29 March 2012
In a decision on 22 March in Teva and ors v AstraZeneca concerning a patent on a sustained release formulation of an anti-psychotic drug, Mr Justice Arnold revoked the patent due to obviousness.
​